SCHEMBL13779295

SCHEMBL13779295

CCN1C(=O)/C(=C\c2ccc(O)cc2O)SC1=S

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4B Q07343 2/20 0.58
▸ MEN1 O00255 9/20 0.57
▸ KMT2A Q03164 9/20 0.57
▸ MAPT P10636 6/20 0.57
▸ ALDH1A1 P00352 5/20 0.57
▸ LMNA P02545 2/20 0.57
▸ RAB9A P51151 2/20 0.57
▸ NPC1 O15118 1/20 0.57
▸ IDE P14735 1/20 0.57
▸ ALOX12 P18054 1/20 0.57
▸ TNNI3 P19429 1/20 0.57
▸ TNNT2 P45379 1/20 0.57
▸ TNNC1 P63316 1/20 0.57
▸ TDP1 Q9NUW8 3/20 0.52
▸ GFER P55789 2/20 0.48
▸ PSMD14 O00487 1/20 0.48
▸ PKM P14618 1/20 0.48
▸ MAPK1 P28482 3/20 0.48
▸ NSD2 O96028 2/20 0.48
▸ POLB P06746 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12866322 0.85 PTPN12 (0.58) MEN1KMT2AMAPTGFERPSMD14
SCHEMBL13236128 0.84 PDE4B (0.53) PDE4BMEN1KMT2AMAPTALDH1A1
SCHEMBL12008577 0.83 PPARG (0.67) MEN1KMT2AMAPTALDH1A1RAB9A
SCHEMBL18857854 0.81 MEN1 (0.68) PDE4BMEN1KMT2AMAPTALDH1A1
SCHEMBL13727245 0.81 MEN1 (0.68) PDE4BMEN1KMT2AMAPTALDH1A1
SCHEMBL13727246 0.81 MEN1 (0.68) PDE4BMEN1KMT2AMAPTALDH1A1
SCHEMBL13726902 0.80 PDE4B (0.58) PDE4BMEN1KMT2AMAPTALDH1A1
SCHEMBL13726901 0.80 PDE4B (0.58) PDE4BMEN1KMT2AMAPTALDH1A1
SCHEMBL18103095 0.80 MEN1 (0.72) PDE4BMEN1KMT2AMAPTALDH1A1
SCHEMBL14777217 0.78 PDE4B (0.76) PDE4BMEN1KMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176773-A1 Non-Peptidic Inhibitors of AKAP/PKA Interaction FORSCHUNGSVERBUND BERLIN E.V. (DE) 2009-07-09 — — US disclosed
US-20090176773-A1 Non-Peptidic Inhibitors of AKAP/PKA Interaction FORSCHUNGSVERBUND BERLIN E.V. (DE) 2009-07-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176773-A1 Non-Peptidic Inhibitors of AKAP/PKA Interaction PRKCH, AIP, PRKCE PDE4B 184/4885MEN1 4118/4885KMT2A 2487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback